07:00 , Jun 25, 2009 |  BC Innovations  |  Strategy

Science for export

Although every major university or institute would like to be located in a biotech hub and keep its discoveries close to home, only a few true hubs exist. For everyone else, the question is whether...
07:00 , Oct 13, 2008 |  BC Week In Review  |  Company News

Calistoga management update

Calistoga Pharmaceuticals Inc. , Seattle, Wash.   Business: Cancer, Inflammation   Hired: Carol Gallagher as CEO, formerly president and CEO of Metastatix Inc.  ...
01:29 , Oct 9, 2008 |  BC Extra  |  Company News

Calistoga names Gallagher CEO

Cancer and inflammation company Calistoga (Seattle, Wash.) hired Carol Gallagher as CEO. Previously, she was president and CEO of cancer company Metastatix (Tucker, Ga.)....
07:00 , Sep 4, 2008 |  BC Innovations  |  Targets & Mechanisms

CXCR4 for CNS Infections

The purpose of the blood-brain barrier is to limit trafficking of leukocytes into the immune-privileged CNS. However, this becomes an undesirable trait when trying to clear acute CNS infections. 1 Indeed, one component of the...
08:00 , Feb 7, 2008 |  BC Innovations  |  Targets & Mechanisms

Unraveling Bv8

Researchers at Genentech Inc. have added three big pieces to the puzzle of how prokineticin 2 ( PROK2 ; Bv8 ), a cytokine secreted by myeloid cells in the bone marrow, regulates tumor-related angiogenesis. The...
08:00 , Dec 10, 2007 |  BC Week In Review  |  Clinical News

MSX-122: Phase I started

Metastatix began an open-label, dose-escalation, U.S. Phase I trial in patients. Metastatix Inc. , Tucker, Ga.   Product: MSX-122   Business: Cancer   Molecular target: CXC chemokine receptor 4 ( CXCR4 )   Description: CXC...
08:00 , Nov 12, 2007 |  BC Week In Review  |  Clinical News

MSX-122: Submitted IND

Metastatix submitted an IND to begin a Phase I trial. Metastatix Inc. , Tucker, Ga.   Product: MSX-122   Business: Cancer   Molecular target: CXC chemokine receptor 4 ( CXCR4 )   Description: CXC chemokine...
07:00 , Oct 22, 2007 |  BC Week In Review  |  Company News

Metastatix management update

Metastatix Inc. , Tucker, Ga.   Business: Cancer, Infectious   Hired: Carol Gallagher as president and CEO, formerly SVP of corporate development and commercial affairs at Anadys Pharmaceuticals Inc.  ...
07:00 , Oct 15, 2007 |  BC Week In Review  |  Company News

Metastatix board of directors update

Metastatix Inc. , Tucker, Ga.   Business: Cancer, Infectious   Appointed: James Topper, general partner of Frazier Healthcare Ventures  ...
01:13 , Oct 10, 2007 |  BC Extra  |  Financial News

Metastatix raises $35 million

Metastatix (Tucker, Ga.) raised $35 million in a series B round led by Frazier Healthcare Ventures. Existing investors H.I.G. Ventures; Aurora Funds; CM Capital; SR One; MedImmune Ventures; Georgia Venture Partners; Centrosome Ventures; and the...